Costs May Not Outweigh Benefits Of Expanding Current HPV Vaccine Guidelines, Research Indicates

Healio (12/10, Michael) reports, “Expanding the current HPV vaccination program in the United States to include men and women up to age 45 years may only produce small additional benefits and is not nearly as cost-effective as it is among younger age grou...